[Tumor necrotic factor as an inhibitor of angiogenesis].
Sopotsinskaia
E B
EB
Lisniak
I A
IA
D000482:Allantois / Q000098:blood supply* / Q000187:drug effects; D043925:Angiogenesis Inducing Agents / Q000037:antagonists & inhibitors* / Q000494:pharmacology; D020533:Angiogenesis Inhibitors; D000818:Animals; D002642:Chick Embryo; D002823:Chorion / Q000098:blood supply* / Q000187:drug effects; D005321:Extraembryonic Membranes / Q000098:blood supply*; D006131:Growth Inhibitors; D009389:Neovascularization, Pathologic; D011506:Proteins / Q000302:isolation & purification / Q000494:pharmacology*; D011817:Rabbits; D014409:Tumor Necrosis Factor-alpha / Q000302:isolation & purification / Q000494:pharmacology*
D043925:Angiogenesis Inducing Agents; D020533:Angiogenesis Inhibitors; D006131:Growth Inhibitors; D011506:Proteins; D014409:Tumor Necrosis Factor-alpha
Opukholevyĭ nekroticheskiĭ faktor kak ingibitor angiogeneza.